[Carbonyl derivatives of tilorone. Part 2: On the cancerostatic activity of carbonyl derivatives of tilorone (author's transl)]
- PMID: 482327
[Carbonyl derivatives of tilorone. Part 2: On the cancerostatic activity of carbonyl derivatives of tilorone (author's transl)]
Abstract
A series of carbonyl derivatives of tilorone was synthetized by reaction with appropriate amino compounds, mainly hydrazines and hydrazides. The condensation products obtained were tested for cancerostatic activity against the murine leucaemia L 1210 and the Walker carcinosarcoma of the rat. Only three of the substances under investigation (1a, 5, 13) proved active against the Walker carcinosarcoma, one of which (5) being comparable to tilorone. No activity against L 1210 was observed, even tilorone exerted no effect. The reduction in activity against the Walker carcinosarcoma which resulted from the carbonyl substitution might be caused by a decrease in the ability to intercalate into DNA.
Similar articles
-
[N-quaternary derivatives of tilorone].Pharmazie. 1984 May;39(5):320-2. Pharmazie. 1984. PMID: 6473490 German.
-
Interaction of DNA with tilorone derivatives: viscometric investigations.Biomed Biochim Acta. 1985;44(7-8):1095-103. Biomed Biochim Acta. 1985. PMID: 4084265
-
Some antitumor agents derived from benzaldehyde nitrogen mustards.Acta Pharm Suec. 1970 Apr;7(2):87-104. Acta Pharm Suec. 1970. PMID: 5421623 No abstract available.
-
Tilorone and related bis-basic substituted polycyclic aromatic and heteroaromatic compounds.Prog Med Chem. 1981;18:135-90. doi: 10.1016/s0079-6468(08)70319-9. Prog Med Chem. 1981. PMID: 7045982 Review. No abstract available.
-
The biological activity of the synthetic polyanion, pyran copolymer (diveema, MVE, 46015) and the heterocyclic bis DEAE fluorenone derivative, tilorone and congeners: clinical and laboratory effects of these agents as modulators of host resistance.Pharmacol Ther. 1981;15(1):1-44. doi: 10.1016/0163-7258(81)90014-0. Pharmacol Ther. 1981. PMID: 7038712 Review. No abstract available.